{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T18:49:28Z","timestamp":1770058168007,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1998,2,1]],"date-time":"1998-02-01T00:00:00Z","timestamp":886291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":8059,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1998,2]]},"DOI":"10.1023\/a:1008204911774","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T08:47:34Z","timestamp":1040546854000},"page":"217-219","source":"Crossref","is-referenced-by-count":15,"title":["A phase II study of oral clofazimine in unresectable and metastatic hepatocellular carcinoma"],"prefix":"10.1016","volume":"9","author":[{"given":"P.","family":"Ruff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Chasen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.H.","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.E.J.","family":"van Rensburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008204911774_bb0010","series-title":"Cancer Incidence in Five Continents","first-page":"88","volume":"V","author":"Muir","year":"1989"},{"key":"10.1023\/A:1008204911774_bb0015","series-title":"Neoplasms of the Liver","article-title":"Epidemiology of hepatocellular carcinoma","author":"Munoz","year":"1987"},{"key":"10.1023\/A:1008204911774_bb0020","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1002\/hep.1840040703","article-title":"Prognosis of primary hepatocellular carcinoma","volume":"4","author":"Okuda","year":"1984","journal-title":"Hepatology"},{"key":"10.1023\/A:1008204911774_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0305-7372(88)90007-2","article-title":"Clinical trials in primary hepatocellular carcinoma: Current status and future directions","volume":"15","author":"Nerenstone","year":"1988","journal-title":"Cancer Treat Rev"},{"key":"10.1023\/A:1008204911774_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1008285123736","article-title":"Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials","volume":"8","author":"Simonetti","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008204911774_bb0035","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1023\/A:1008249328792","article-title":"A phase II study of raltitrexed (Tomudex\u2019) in patients with hepatocellular carcinoma","volume":"8","author":"Rougier","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008204911774_bb0040","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/162622a0","article-title":"Antitubercular activity of oxidation products of o-phenylediamines","volume":"162","author":"Barry","year":"1948","journal-title":"Nature (London)"},{"key":"10.1023\/A:1008204911774_bb0045","first-page":"318","article-title":"The riminophenazine agents clofazimine and B669 inhibit proliferation of cancer cell lines in vitro by phospholipase A2 mediated oxidative and non-oxidative mechanisms","volume":"53","author":"Van Rensburg","year":"1993","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008204911774_bb0050","first-page":"1115","article-title":"The antiproliferative riminophenazine agents clofazimine and B669 promote lysophospholipid mediated inhibition of Na+, K+ adenosine triphosphate activity in cancer cell lines in vitro","volume":"4","author":"Van Rensburg","year":"1994","journal-title":"Int J Oncol"},{"key":"10.1023\/A:1008204911774_bb0055","first-page":"1011","article-title":"Evaluation of the antineoplastic activities of the riminophenazine agents clofazimine and B669 in tumour bearing rats and mice","volume":"3","author":"Van Rensburg","year":"1993","journal-title":"Int J Oncol"},{"key":"10.1023\/A:1008204911774_bb0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2165\/00003088-198916020-00002","article-title":"Clinical pharmacokinetics of clofazimine: A review","volume":"16","author":"Holdiness","year":"1989","journal-title":"Clin Pharmacokinet"},{"key":"10.1023\/A:1008204911774_bb0065","first-page":"9","article-title":"Pharmacokinetics of clofazimine in healthy volunteers","volume":"55","author":"Schaad-Lanyi","year":"1987","journal-title":"Int J Lepr"},{"key":"10.1023\/A:1008204911774_bb0070","first-page":"146","article-title":"Evaluation of the effectiveness of clofazimine therapy 1: Monitoring of absorption of clofazimine from the gastro-intestinal tract","volume":"57","author":"Mathur","year":"1985","journal-title":"Indian J Lepr"},{"key":"10.1023\/A:1008204911774_bb0075","series-title":"Differential expression of extracellular matrix and integrins in hepatocellular carcinoma and other diseases","first-page":"355","author":"Chasen","year":"1994"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419553571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419553571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/9\/2\/217\/19481854\/9-2-217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T12:17:33Z","timestamp":1582633053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419553571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["S0923753419553571"],"URL":"https:\/\/doi.org\/10.1023\/a:1008204911774","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1998,2]]}}}